Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen
- PMID: 15389669
- DOI: 10.1002/jps.20182
Ability of polyvinylpyrrolidone and polyacrylic acid to inhibit the crystallization of amorphous acetaminophen
Abstract
The inhibition of crystallization of amorphous acetaminophen (ACTA) by polyvinylpyrrolidone (PVP) and polyacrylic acid (PAA) was studied using amorphous solid dispersions prepared by melt quenching. Co-melting with PVP and PAA decreased the average molecular mobility, as indicated by increases in glass transition temperature and enthalpy relaxation time. The ACTA/PAA dispersion exhibited much slower crystallization than the ACTA/PVP dispersion with a similar glass transition temperature value, indicating that interaction between ACTA and polymers also contributed to the stabilizing effect of these polymers. The carboxyl group of PAA may interact with the hydroxyl group of ACTA more intensely than the carbonyl group of PVP does, resulting in the stronger stabilizing effect of PAA. Dielectric relaxation spectroscopy showed that the number of water molecules tightly binding to PVP per monomer unit was larger than that to PAA. Furthermore, a small amount of absorbed water decreased the stabilizing effect of PVP, but not that of PAA. These findings suggest that the stronger stabilizing effect of PAA is due to the stronger interaction with ACTA. The ability of PAA to decrease the molecular mobility of solid dispersion was also larger than that of PVP, as indicated by the longer enthalpy relaxation time.
Similar articles
-
Role of the Strength of Drug-Polymer Interactions on the Molecular Mobility and Crystallization Inhibition in Ketoconazole Solid Dispersions.Mol Pharm. 2015 Sep 8;12(9):3339-50. doi: 10.1021/acs.molpharmaceut.5b00333. Epub 2015 Jul 30. Mol Pharm. 2015. PMID: 26070543
-
The role of drug-polymer hydrogen bonding interactions on the molecular mobility and physical stability of nifedipine solid dispersions.Mol Pharm. 2015 Jan 5;12(1):162-70. doi: 10.1021/mp5005146. Epub 2014 Nov 26. Mol Pharm. 2015. PMID: 25426538
-
Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions.J Pharm Sci. 2004 Feb;93(2):384-91. doi: 10.1002/jps.10526. J Pharm Sci. 2004. PMID: 14705195
-
Understanding the generation and maintenance of supersaturation during the dissolution of amorphous solid dispersions using modulated DSC and 1H NMR.Int J Pharm. 2018 Jan 30;536(1):414-425. doi: 10.1016/j.ijpharm.2017.11.056. Epub 2017 Nov 26. Int J Pharm. 2018. PMID: 29183857
-
Mechanism of amorphous itraconazole stabilization in polymer solid dispersions: role of molecular mobility.Mol Pharm. 2014 Nov 3;11(11):4228-37. doi: 10.1021/mp5004515. Epub 2014 Oct 17. Mol Pharm. 2014. PMID: 25325389
Cited by
-
Evaluation of drug-polymer miscibility in amorphous solid dispersion systems.Pharm Res. 2009 Nov;26(11):2523-34. doi: 10.1007/s11095-009-9970-7. Epub 2009 Sep 22. Pharm Res. 2009. PMID: 19771495
-
Effects of Excipient Interactions on the State of the Freeze-Concentrate and Protein Stability.Pharm Res. 2017 Feb;34(2):462-478. doi: 10.1007/s11095-016-2078-y. Epub 2016 Dec 15. Pharm Res. 2017. PMID: 27981449
-
Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.Pharm Res. 2006 Oct;23(10):2417-26. doi: 10.1007/s11095-006-9063-9. Epub 2006 Aug 24. Pharm Res. 2006. PMID: 16933098
-
Binary Graft of Poly(acrylic acid) and Poly(vinyl pyrrolidone) onto PDMS Films for Load and Release of Ciprofloxacin.Polymers (Basel). 2023 Jan 6;15(2):302. doi: 10.3390/polym15020302. Polymers (Basel). 2023. PMID: 36679182 Free PMC article.
-
Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.Pharm Res. 2008 Apr;25(4):969-78. doi: 10.1007/s11095-007-9331-3. Epub 2007 May 23. Pharm Res. 2008. PMID: 17520180
MeSH terms
Substances
LinkOut - more resources
Full Text Sources